New Antibody Can Reduce Swelling Attacks in Patients With Hereditary Angioedema
Patients with hereditary angioedema experience recurrent and sometimes life-threatening swelling attacks. Researchers from Charité – Universitätsmedizin Berlin have tested an antibody capable of reducing the frequency of these swelling attacks by more than 90%. Results from their phase 3 trial were published yesterday in JAMA, the renowned Journal of the American Medical Association